NCT07696260 Evaluation of Alexithymia and Its Relationship With Clinical Parameters in Patients With Chronic Coccydynia
| NCT ID | NCT07696260 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marmara University |
| Condition | Chronic Coccydynia |
| Study Type | OBSERVATIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-03-20 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15 participants in total. It began in 2026-03-20 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the prevalence and levels of alexithymia in patients diagnosed with chronic coccydynia (tailbone pain lasting for 3 months or longer) and to explore its relationship with various clinical and psychological parameters. Chronic coccydynia can significantly impair daily activities, functionality, and reduce quality of life. Participants in this prospective, observational study will be evaluated during their routine visits to the pain management clinic. Evaluation of the participants will be performed using validated self-report questionnaires, including the Toronto Alexithymia Scale (TAS-20) for alexithymia, the Hospital Anxiety and Depression Scale (HADS) for mood symptoms, the Childhood Trauma Questionnaire (CTQ-33) for early life adverse experiences, the Visual Analog Scale (VAS) for pain intensity, and the 12-Item Short Form Health Survey (SF-12) for quality of life. The primary objective of the study is to determine how alexithymia relates to pain severity, duration, emotional symptoms, childhood trauma history, and overall quality of life in this specific population. The results of this pilot study may help strengthen the biopsychosocial approach in the evaluation of chronic coccydynia and optimize future multidisciplinary treatment strategies.
Eligibility Criteria
Inclusion Criteria: Being older than 18 years of age * Volunteering to participate in the study and providing written informed consent * Being literate and having the mental capacity to comprehend the questionnaires * Having no active, treated severe psychiatric disorder (such as schizophrenia or bipolar affective disorder) Exclusion Criteria: * \- Cognitive impairment or communication barriers that compromise the capacity to consent * Active psychotic disorder or manic episode * Suspected self-harm or suicide risk during the clinical interview * Distinct secondary causes of pain such as malignancy, active infection, or acute fracture
Frequently Asked Questions
Who can join the NCT07696260 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Coccydynia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07696260 currently recruiting?
Yes, NCT07696260 is actively recruiting participants. Visit ClinicalTrials.gov or contact Marmara University to inquire about joining.
Where is the NCT07696260 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07696260 clinical trial?
NCT07696260 is sponsored by Marmara University. The trial plans to enroll 15 participants.